cornellleukemia.com
FDA Approves CAR T-Cell Therapy for Kids and Young Adults with Acute Lymphoblastic Leukemia
On August 30, 2017, the United States Food and Drug Administration (FDA) approved the cell-based gene therapy Kymriah for treatment of children and young adults with a certain form of acute lymphob…